|
|
|
Volumn 24, Issue 4 SUPPL. 13, 1997, Pages
|
|
Docetaxel as single-agent therapy in metastatic breast cancer: Clinical efficacy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTHRAQUINONE;
CORTICOSTEROID;
DOCETAXEL;
MELPHALAN;
NAVELBINE;
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
BINDING AFFINITY;
BREAST CANCER;
CANCER THERAPY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORTICOSTEROID BLOOD LEVEL;
DOSE RESPONSE;
DRUG SAFETY;
FLUID RETENTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
METASTASIS;
MUCOSA INFLAMMATION;
NEUROPATHY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECEPTOR BINDING;
SKIN ALLERGY;
TREATMENT PLANNING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CLINICAL TRIALS;
FEMALE;
HUMANS;
NEOPLASM METASTASIS;
NEUTROPENIA;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0030860617
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (54)
|
|
References (39)
|
